HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Will Propose Drug GMP Quality Management Systems By December

This article was originally published in The Tan Sheet

Executive Summary

FDA expects to release a draft on improving the agency's drug GMP management systems by Dec. 1

You may also be interested in...



PAT Data Will Not Be Evaluated During Drug Inspections – FDA

As a general policy, FDA will not look at process analytical technology research data during drug inspections, FDA New Jersey District Director Douglas Ellsworth asserted during a recent industry-sponsored conference

PAT Selective Implementation Advised As Cost Control Measure

The cost to pharmaceutical manufacturers of operating process analytical technology often is more than the cost of implementing it, according to Pfizer Drug Product Technology Senior Manager Joep Timmermans

CDER Deputy Galson Will Run Drug Center For At Least Six Months

Center for Drug Evaluation & Research Deputy Director Steve Galson, MD, will be acting center director during the period when FDA is expected to announce a decision on forced Rx-to-OTC switches

Related Content

Topics

UsernamePublicRestriction

Register

RS129789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel